Kongressthemen
With race to market for the first allogeneic and solid tumor targeting cell immunotherapy well and truly on, the explosive excitement in Gamma Delta T Therapies continues to increase, as we begin to see the early clinical data read out on safety and efficacy.
The annual Gamma Delta T Therapies Summit returns online as a 3 day virtual event gathering the world’s leaders harnessing GDT cells to bring to market the first effective, allogeneic cell therapy for solid tumors.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/746170-0?pid=4832
Speakers: Lawrence Lamb, Chief Scientific Officer, IN8Bio, Mihriban Tuna, Chief Scientific Officer, Adaptate Biotherapeutics and more
https://go.evvnt.com/746170-1?pid=4832
Herr Gamma Delta T Therapies Team
KategorienAllgemeinmedizin, Klinische Forschung
